IMUX

$7.60+3.54%visit website

IMMUNIC, INC.

Market Cap

$104M

Live price × Finnhub shares (2026-09-20)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.47

60mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	20,012	19,069	25,626	25,931	90,638
Total operating expenses	25,993	23,327	33,235	35,327	117,882
Operating income	(25,993)	(23,327)	(33,235)	(35,327)	(117,882)
Net income	(25,579)	(19,300)	(32,588)	(34,099)	(111,566)
EPS (basic) ($)	(1.95)		(1.08)	(0.80)	—
EPS (diluted) ($)	(1.95)		(1.08)	(0.80)	—
Weighted avg. shares (basic)	12,927		30,136	42,514
Weighted avg. shares (diluted)	12,927		30,136	42,514

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 11, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 50 more quarters, back to Mar 2013, with Tormere Pro.

Corporate Events (8-K)

21 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Sep 11, 2026 accepted 5:24 PM ET	5.02Officer / director change	Document SEC ↗
Sep 9, 2026 accepted 9:01 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 11, 2026 accepted 7:05 AM ET	2.02Earnings release5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Jul 14, 2026 accepted 8:01 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jul 6, 2026 accepted 4:22 PM ET	5.02Officer / director change	Document SEC ↗
Jun 29, 2026 accepted 4:05 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 28, 2026 accepted 7:01 AM ET	7.01Reg FD disclosure	Document SEC ↗
May 27, 2026 accepted 7:00 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
May 19, 2026 accepted 7:00 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
May 13, 2026 accepted 7:01 AM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

55%

W/W +19.6pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

META_TITLE_QUOTE

Yahoo Finance · 2026-11-04

Immunic to Participate in Investor Conferences in November

Yahoo · 2026-11-02

Immunic highlights progressive MS research and Phase 3 outlook at MSToronto2026

Yahoo · 2026-10-30

Immunic to host R&D Day on progressive multiple sclerosis

Yahoo · 2026-10-29

Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026

Yahoo · 2026-10-29

Immunic, Inc. (IMUX) Presents at 10th Joint ACTRIMS-ECTRIMS Meeting - MSToronto2026 - Slideshow

SeekingAlpha · 2026-10-27

Cantor Fitzgerald Initiates Coverage On Immunic with Overweight Rating

Benzinga · 2026-10-23

New Strong Buy Stocks for October 22nd

Yahoo · 2026-10-22

Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting

Yahoo · 2026-10-21

Immunic to showcase phase 2 long-term MS disability data at MSToronto2026

Yahoo · 2026-10-19

Immunic adds new Chief People Officer ahead of Phase 3 readout

Yahoo · 2026-10-19

Immunic Appoints Jaa Roberson as Chief People Officer

Yahoo · 2026-10-19

Immunic to present four vidofludimus calcium abstracts at MSToronto2026

Yahoo · 2026-10-07

Seven new Immunic employees get stock options tied to 196,350 shares

Stock Titan · 2026-09-29

Immunic Inc (NASDAQ: IMUX) Share Price, IMUX Stock News, IMUX Share Price & Updates

Kalkine · 2026-08-10

Informational purposes only, not investment advice.

Corporate Events (8-K)

21 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Sep 11, 2026 accepted 5:24 PM ET	5.02Officer / director change	Document SEC ↗
Sep 9, 2026 accepted 9:01 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 11, 2026 accepted 7:05 AM ET	2.02Earnings release5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Jul 14, 2026 accepted 8:01 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jul 6, 2026 accepted 4:22 PM ET	5.02Officer / director change	Document SEC ↗
Jun 29, 2026 accepted 4:05 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 28, 2026 accepted 7:01 AM ET	7.01Reg FD disclosure	Document SEC ↗
May 27, 2026 accepted 7:00 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
May 19, 2026 accepted 7:00 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
May 13, 2026 accepted 7:01 AM ET	2.02Earnings release	Document SEC ↗

IMUX

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

IMMUNIC, INC. (IMUX)

Factor Profile

Corporate Events (8-K)